Part of the PCOS Knowledge Library
What You Need to Know About Hormones and Cystic Acne: An Ayurvedic Perspective
Introduction
Cystic acne is one of the most severe forms of acne vulgaris, characterized by deep, inflamed, and painful cysts that can lead to scarring and significant emotional distress (James, Berger, & Elston, 2016). Unlike regular acne, cystic acne forms when oil and dead skin cells build up deep within hair follicles, creating large pus-filled nodules. It predominantly affects adolescents and young adults but can persist into adulthood, especially in women (Zaenglein et al., 2016).
Hormonal fluctuations play a pivotal role in the development of cystic acne. These hormonal imbalances can stem from natural life stages like puberty and menstruation or from conditions such as Polycystic Ovary Syndrome (PCOS) and stress-related hormonal changes (Kilic et al., 2016). While conventional treatments, including antibiotics, retinoids, and hormonal therapies, may provide temporary relief, they often come with side effects and fail to address the root causes (Purvis et al., 2006).
Ayurveda, the ancient Indian system of medicine, offers a holistic approach to managing cystic acne by balancing hormones, detoxifying the body, and restoring harmony among the body’s energies (doshas) (Lad, 2002). At EliteAyurveda, we integrate these time-tested principles with modern insights to provide personalized, effective solutions for cystic acne.
About Hormones and Cystic Acne: An Ayurvedic Perspective
Hormonal fluctuations are a primary trigger for cystic acne, influencing sebum production, skin cell turnover, and inflammation (Thiboutot et al., 2009). Key hormonal factors include:
These hormonal imbalances increase sebum production, promote hyperkeratinization, and create an environment conducive to the proliferation of Cutibacterium acnes (formerly Propionibacterium acnes), leading to inflammation and cyst formation (Dreno et al., 2015).
In Ayurveda, cystic acne is considered a manifestation of imbalances in the Pitta and Kapha doshas (Lad, 2002):
Ayurvedic treatment focuses on restoring doshic balance, enhancing digestion (Agni), and eliminating toxins to address the root causes of cystic acne (Sharma et al., 2013).
Ayurveda treats cystic acne holistically, focusing on individual constitution (Prakriti) and current imbalances (Vikruti) (Lad, 2002). The treatment encompasses detoxification, herbal remedies, dietary modifications, and lifestyle changes.
Patient Profile:
Treatment Plan:
Outcome:
Cystic acne is more than a superficial skin condition; it reflects deeper imbalances within the body, particularly hormonal disturbances and toxin accumulation (Mishra et al., 2001). While conventional treatments may offer temporary relief, Ayurveda provides a comprehensive, natural approach that not only alleviates symptoms but also addresses the root causes, ensuring long-term healing and prevention of recurrence (Sharma et al., 2013).
At EliteAyurveda, we empower patients to achieve clear, healthy skin through personalized care that harmonizes the body, mind, and spirit. By integrating ancient wisdom with modern insights, we offer a path to lasting wellness and rejuvenation.
Take the first step toward clear, balanced skin today.
📞 Contact us at +91 8884722246
🌐 Visit our website: www.eliteayurveda.com
Related-
Know More About Ayurveda Treatment For skin conditions
GET IN TOUCH
Contact us
1.Zaenglein A. L. Acne vulgaris. New England Journal of Medicine . 2018;379(14):1343–1352. doi: 10.1056/nejmcp1702493. [DOI] [PubMed] [Google Scholar]
2.Bhate K., Williams H. C. Epidemiology of acne vulgaris. British Journal of Dermatology . 2013;168(3):474–485. doi: 10.1111/bjd.12149. [DOI] [PubMed] [Google Scholar]
3.Tan J. K. L., Bhate K. A global perspective on the epidemiology of acne. British Journal of Dermatology . 2015;172(1):3–12. doi: 10.1111/bjd.13462. [DOI] [PubMed] [Google Scholar]
4.Dréno B., Jean-Decoster C., Georgescu V. Profile of patients with mild-to-moderate acne in Europe: a survey. European Journal of Dermatology . 2016;26(2):177–184. doi: 10.1684/ejd.2015.2722. [DOI] [PubMed] [Google Scholar]
5.Rocha M. A., Bagatin E. Adult-onset acne: prevalence, impact, and management challenges. Clinical, Cosmetic and Investigational Dermatology . 2018;11:59–69. doi: 10.2147/ccid.s137794. [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Vieira da Costa I., Cardoso da Cunha Velho G. M. Acne vulgar no adulto. Journal of the Portuguese Society of Dermatology and Venereology . 2018;76(3):299–312. doi: 10.29021/spdv.76.3.953. [DOI] [Google Scholar]
7.Williams H. C., Dellavalle R. P., Garner S. Acne vulgaris. The Lancet . 2012;379(9813):361–372. doi: 10.1016/s0140-6736(11)60321-8. [DOI] [PubMed] [Google Scholar]
8.Thomas D. R. Psychosocial effects of acne. Journal of Cutaneous Medicine and Surgery . 2005;8(4):3–5. doi: 10.1007/s10227-004-0752-x. [DOI] [PubMed] [Google Scholar]
9.Gallitano S. M., Berson D. S. How acne bumps cause the blues: the influence of acne vulgaris on self-esteem. International Journal of Women’s Dermatology . 2018;4(1):12–17. doi: 10.1016/j.ijwd.2017.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Ogé L. K., Broussard A., Marshall M. D. Acne vulgaris: diagnosis and treatment. American Family Physician . 2019;100(8):475–484. [PubMed] [Google Scholar]
11.França K., Keri J. Psychosocial impact of acne and postinflammatory hyperpigmentation. Anais Brasileiros de Dermatologia . 2017;92(4):505–509. doi: 10.1590/abd1806-4841.20175645. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Prasad S. B. Acne vulgaris: a review on pathophysiology and treatment. Asian Journal of Pharmaceutical and Clinical Research . 2016;9(4):54–59. [Google Scholar]
13.Gollnick H. P. M. From new findings in acne pathogenesis to new approaches in treatment. Journal of the European Academy of Dermatology and Venereology . 2015;29:1–7. doi: 10.1111/jdv.13186. [DOI] [PubMed] [Google Scholar]
14.Clayton R. W., Göbel K., Niessen C. M., Paus R., Steensel M., Lim X. Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis. British Journal of Dermatology . 2019;181(4):677–690. doi: 10.1111/bjd.17981. [DOI] [PubMed] [Google Scholar]
15.Picardo M., Ottaviani M., Camera E., Mastrofrancesco A. Sebaceous gland lipids. Dermato-Endocrinology . 2009;1(2):68–71. doi: 10.4161/derm.1.2.8472. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Cong T. X., Hao D., Wen X., Li X. H., He G., Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Archives of Dermatological Research . 2019;311(5):337–349. doi: 10.1007/s00403-019-01908-x. [DOI] [PubMed] [Google Scholar]
17.Downing D. T., Stewart M. E., Wertz P. W., Strauss J. S. Essential fatty acids and acne. Journal of the American Academy of Dermatology . 1986;14(2):221–225. doi: 10.1016/s0190-9622(86)70025-x. [DOI] [PubMed] [Google Scholar]
18.Kurokawa I., Danby F. W., Ju Q., et al. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology . 2009;18(10):821–832. doi: 10.1111/j.1600-0625.2009.00890.x. [DOI] [PubMed] [Google Scholar]
19.Zaenglein A. L., Thiboutot D. M. Expert committee recommendations for acne management. Pediatrics . 2006;118(3):1188–1199. doi: 10.1542/peds.2005-2022. [DOI] [PubMed] [Google Scholar]
20.Valins W., Amini S., Berman B. The expression of toll-like receptors in dermatological diseases and the therapeutic effect of current and newer topical toll-like receptor modulators. The Journal of clinical and aesthetic dermatology . 2010;3(9):20–29. [PMC free article] [PubMed] [Google Scholar]
21.Beylot C., Auffret N., Poli F., et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. Journal of the European Academy of Dermatology and Venereology . 2014;28(3):271–278. doi: 10.1111/jdv.12224. [DOI] [PubMed] [Google Scholar]
22.Kim J., Ochoa M. T., Krutzik S. R., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. The Journal of Immunology . 2002;169(3):1535–1541. doi: 10.4049/jimmunol.169.3.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Dréno B., Pécastaings S., Corvec S., Veraldi S., Khammari A., Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. Journal of the European Academy of Dermatology and Venereology . 2018;32:5–14. doi: 10.1111/jdv.15043. [DOI] [PubMed] [Google Scholar]
24.Jugeau S., Tenaud I., Knol A., et al. Induction of toll-like receptors by Propionibacterium acnes. British Journal of Dermatology . 2005;153(6):1105–1113. doi: 10.1111/j.1365-2133.2005.06933.x. [DOI] [PubMed] [Google Scholar]
25.Jahns A. C., Lundskog B., Ganceviciene R., et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. British Journal of Dermatology . 2012;167(1):50–58. doi: 10.1111/j.1365-2133.2012.10897.x. [DOI] [PubMed] [Google Scholar]
26.Nast A., Dreno B., Bettoli V., et al. European evidence-based (S3) guideline for the treatment of acne–update 2016–short version. Journal of the European Academy of Dermatology and Venereology . 2016;30(8):1261–1268. doi: 10.1111/jdv.13776. [DOI] [PubMed] [Google Scholar]
27.Fox L., Csongradi C., Aucamp M., Plessis J. D., Gerber M. Treatment modalities for acne. Molecules . 2016;21(8):p. 1063. doi: 10.3390/molecules21081063. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Kosmadaki M., Katsambas A. Topical treatments for acne. Clinics in Dermatology . 2017;35(2):173–178. doi: 10.1016/j.clindermatol.2016.10.010. [DOI] [PubMed] [Google Scholar]
29.Savage L. J., Layton A. M. Treating acne vulgaris: systemic, local and combination therapy. Expert Review of Clinical Pharmacology . 2010;3(4):563–580. doi: 10.1586/ecp.10.27. [DOI] [PubMed] [Google Scholar]
30.Cao H., Yang G., Wang Y., et al. Complementary therapies for acne vulgaris. Cochrane Database of Systematic Reviews . 2015;1 doi: 10.1002/14651858.cd009436.pub2.CD009436 [DOI] [PMC free article] [PubMed] [Google Scholar]
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.